Closing the gap between your biological and actual age may shield the brain from stroke

American Academy of Neurology, preliminary study to be presented at the 78th Annual Meeting, April 2026.

At 56, your birth certificate says one thing. Your blood might say another. Eighteen biomarkers, from cholesterol levels to white blood cell counts, can paint a portrait of how quickly your body is actually aging. And according to a large new study, the distance between those two numbers may matter more for your brain than anyone previously appreciated.

An analysis of more than 258,000 participants from a health care research database found that people whose biological age ran ahead of their chronological age faced a 41% higher risk of stroke and scored worse on tests of memory and thinking. But the more striking finding involved change over time: participants who managed to narrow that gap over a six-year window were 23% less likely to have a stroke during the follow-up period.

What 18 blood markers reveal about brain health

The research team, led by Cyprien Rivier, MD, MSc, of Yale University, used a panel of 18 blood-based biomarkers to calculate biological age at two time points. These markers included cholesterol, average red blood cell volume, and white blood cell count, among others. Participants had their blood drawn at the start of the study and again six years later for a subset of the group. After an average follow-up of 10 years, researchers tracked who developed a stroke. A smaller subset also underwent brain imaging and cognitive testing.

At enrollment, the average participant was chronologically 56 but biologically 54. Six years later, that same group had reached a chronological age of 62 but a biological age of just 58. The gap, in other words, had widened in a favorable direction for some participants.

Those whose biological clocks ran faster than their calendars showed measurably worse outcomes on brain scans. Their white matter hyperintensities, bright spots on MRI that signal damaged tissue, were more extensive. Their cognitive test scores were lower.

A 13% reduction in brain damage for each unit of improvement

The most actionable result came from the longitudinal comparison. People who improved their biological age gap between the two blood draws showed 13% less white matter damage per standard deviation of improvement by the end of the study. The 23% stroke risk reduction held even after the researchers adjusted for confounders including high blood pressure, other vascular conditions, and socioeconomic factors.

"It's exciting to think that working to modify our biological age could be a pathway to preserving brain health," Rivier said. He pointed to lifestyle habits that support cardiovascular and metabolic health as plausible mechanisms, including diet, exercise, sleep, and blood pressure management, though the study itself did not evaluate any specific lifestyle program.

Association, not proof

The study is observational, and the researchers are careful to say it does not establish cause and effect. It shows an association between improving biological age markers and better brain outcomes, not that one directly causes the other. The repeat blood testing was only available for a smaller subgroup, which limits what can be concluded about changes over time, particularly regarding cognitive performance.

There is also a chicken-and-egg question worth raising. People who improved their biomarker profiles may have done so because they were healthier to begin with, or because they adopted lifestyle changes that independently protect the brain. Disentangling the contribution of biological age itself from the behaviors that modify it will require intervention trials.

"More research is needed, testing whether lowering people's biological age gap can be demonstrated to reduce the risk of stroke and later-life brain injury," Rivier said.

Why biological age matters beyond vanity

The concept of biological age has gained traction in recent years, fueled by consumer testing kits and a growing body of research linking accelerated aging to disease risk. But most of that work has focused on outcomes like mortality or cardiovascular events. This study is notable for connecting biological age changes specifically to brain health, including both structural damage visible on imaging and functional decline measurable through cognitive tests.

The practical implication is cautiously optimistic. If biological age is modifiable, and if those modifications track with reduced stroke risk and less brain damage, then the biomarker panel could serve as both a warning system and a progress report. That is a big "if," and the interventional evidence is not yet there. But the correlation across a quarter of a million people is hard to dismiss.

The preliminary findings will be presented at the American Academy of Neurology's 78th Annual Meeting in Chicago, April 18-22, 2026. The study was supported by the AAN/American Heart Association Ralph L. Sacco Scholarship in Brain Health.